Key result
Fixed-dose dual antihypertensives linked to ~88% higher odds of hospitalization for hypotension or syncope.
Why the study?
The safety profile of fixed-dose dual antihypertensive drug combinations compared to component-based free-combinations in older adults was unclear.
Does fixed-dose dual antihypertensive drug combination increase serious adverse events compared to free-combination in adults over 50 initiating therapy?
Case-Control (n=1,698)
Yes
Does fixed-dose dual antihypertensive drug combination increase serious adverse events compared to free-combination in adults over 50 initiating therapy?
Initiating antihypertensive therapy with fixed-dose combinations may increase the early risk of serious adverse events such as hypotension and syncope compared to free combinations in older adults.
Answers are grounded in this paper and cite their sources.
Fixed-dose combinations may raise hypotension hospitalization risk; observational data leaves open causality and need for randomized confirmation.
To compare serious adverse events of fixed-dose dual antihypertensive drug combination (FIXED) to component-based free-combination (FREE).A population-based nationwide cohort from the French Health Insurance System included subjects over 50 years with first time claims (new user) in the second half of 2009 for a calcium-channel blocker or a thiazide-like diuretic in combination with either an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker as FREE or FIXED. We designed a nested matched case-control analysis with 304 cases, hospitalized for hypotension, syncope, or collapse (n = 224), renal failure (n = 19), hyponatremia, hyper- or hypokalemia (n = 61) and 1394 controls matched for gender, age, date of inclusion in the cohort, and administrative county. Subjects with a medical history of cardiovascular disease, chronic renal failure, or cancer were excluded.The mean age ± SD was 73 ± 10 years and 70% were women. Based on the last delivery preceding the index date, 1414 patients (83%) were exposed to FIXED. Homogeneity of FIXED effect compared to FREE across components of the main composite outcome was rejected (P = 0.0099). FIXED formulation significantly increased the odd of the most frequent component (ie, hypotension, syncope, or collapse): OR = 1.88 (95% CI: 1.15-3.05) compared to FREE after adjusting for confounding factors including dose.Serious adverse event occurring in the early phase of treatment deserves attention of physicians because it could alter the benefit/risk ratio of antihypertensive drug combination.
No takes yet. Share an insight, caveat, or question.
Nowak et al. (2015) conducted a case-control in Hypertension (n=1,698). Fixed-dose dual antihypertensive drug combination (FIXED) vs. Component-based free-combination (FREE) was evaluated on Hospitalization for hypotension, syncope, or collapse (OR 1.88, 95% CI 1.15-3.05). Fixed-dose dual antihypertensive combinations increased the odds of hospitalization for hypotension, syncope, or collapse compared to free-combinations.
Synapse has enriched 10 related papers. Consider them for comparative context: